EDIT

AS OF

Nov 13, 04:59 PM (EDT)

Price

$2.54

Change

-$0.15 (-5.56%)

Capitalization

262.59M

98 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

EDIT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Editas Medicine (EDIT) Earnings Date & Reports

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EDIT is expected to report earnings to fall 23.14% to -21 cents per share on February 19

Editas Medicine EDIT Stock Earnings Reports

Q4'25

Est.

$-0.22

Q3'25

Beat

by $0.02

Q2'25

Missed

by $0.23

Q1'25

Missed

by $0.36

Q4'24

Missed

by $0.22

The last earnings report on November 10 showed earnings per share of -28 cents, beating the estimate of -30 cents. With 1.07M shares outstanding, the current market capitalization sits at 262.59M.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+26%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

EDIT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EDIT showed earnings on November 10, 2025. You can read more about the earnings report here.

View AI-Driven Trading for EDIT

A.I. Advisor

published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

11 Hurley Street

Phone

+1 617 401-9000

Employees

265

Web

https://www.editasmedicine.com